Covid19 Clinical Trial
Official title:
COVID-19, the Third Wave Update People Coping With the COVID-19. A Cross-sectional Online Spanish Survey
Due to the pandemic situation, a rapid online survey may be the best method to assess and track people's pandemic cooping. Regarding the huge media influence and the government's restrictions to control the spread of covid-19; it is needed to know more about people's perception and situation to conduct future contentions plans. This study aims to apply a rapid online survey to determine the Spanish situation in this third wave of the pandemic. The survey will be delivered to 1000 participants to obtain a representative sample. It would be divided into six sections (general information, demography data, social and consuming habits, Covi-19 question, questions for Covid-19 positive, and questions for Covid-19 negative).
| Status | Not yet recruiting |
| Enrollment | 1000 |
| Est. completion date | December 20, 2020 |
| Est. primary completion date | December 20, 2020 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | N/A and older |
| Eligibility | Inclusion Criteria: - Owning online connection - Ability to answer and complete the survey Exclusion Criteria: - None |
| Country | Name | City | State |
|---|---|---|---|
| Spain | Universidad de Salamanca | Salamanca |
| Lead Sponsor | Collaborator |
|---|---|
| University of Salamanca |
Spain,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | What's your work or study system nowadays? | Multiple choice questionnaire | 20 seconds | |
| Primary | Habits before the Covid-19 pandemic | Likert scale questionnaire | 60 seconds | |
| Primary | Habits in the Covid-19 pandemic | Likert scale questionnaire | 60 seconds | |
| Primary | Personal Covid-19 exposure and disease | Dichotomous options questionnaire | 10 seconds | |
| Primary | Positive Covid-19: tests, diagnosis, symptoms and quarantine | Multiple choice questionnaire | 60 seconds | |
| Primary | Negative Covid-19: tests and quarantine | Multiple choice questionnaire | 40 seconds | |
| Primary | Expectations | Multiple choice questionnaire | 10 seconds | |
| Secondary | Date of birth | It is registered in the survey to know the age | 20 seconds | |
| Secondary | Sex | It is registered in the survey | 20 seconds | |
| Secondary | Height | It is registered in centimeters | 20 seconds | |
| Secondary | Weight | It is registered in kilograms | 20 seconds | |
| Secondary | Blood type | Multiple choice questionnaire | 20 seconds | |
| Secondary | Pathologic history | Multiple choice questionnaire | 20 seconds | |
| Secondary | Region of residence | Multiple choice questionnaire | 20 seconds | |
| Secondary | City of residence | Multiple choice questionnaire | 20 seconds | |
| Secondary | Rural or urban environment | Dichotomous options questionnaire | 20 seconds | |
| Secondary | Cohabitants in the family unit | The number of cohabitants is registered in the survey | 20 seconds |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05047692 -
Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers
|
Phase 1 | |
| Recruiting |
NCT04395768 -
International ALLIANCE Study of Therapies to Prevent Progression of COVID-19
|
Phase 2 | |
| Terminated |
NCT04555096 -
A Trial of GC4419 in Patients With Critical Illness Due to COVID-19
|
Phase 2 | |
| Completed |
NCT04508777 -
COVID SAFE: COVID-19 Screening Assessment for Exposure
|
||
| Completed |
NCT04506268 -
COVID-19 SAFE Enrollment
|
N/A | |
| Completed |
NCT04961541 -
Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT04546737 -
Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients
|
N/A | |
| Completed |
NCT04532294 -
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants
|
Phase 1 | |
| Completed |
NCT04494646 -
BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19)
|
Phase 2 | |
| Terminated |
NCT04542993 -
Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy
|
Phase 2 | |
| Not yet recruiting |
NCT04543006 -
Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19
|
N/A | |
| Terminated |
NCT04581915 -
PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19
|
Phase 2/Phase 3 | |
| Completed |
NCT04537663 -
Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults
|
Phase 4 | |
| Completed |
NCT04387292 -
Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Not yet recruiting |
NCT04527211 -
Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel
|
Phase 3 | |
| Completed |
NCT04979858 -
Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask
|
N/A | |
| Not yet recruiting |
NCT05038449 -
Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19
|
N/A | |
| Completed |
NCT04610502 -
Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients
|
Phase 2 | |
| Active, not recruiting |
NCT06042855 -
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)
|
Phase 3 |